Sökning: onr:"swepub:oai:DiVA.org:umu-55732" >
Subarachnoid haemor...
-
Rodling Wahlström, MarieUmeå universitet,Anestesiologi och intensivvård
(författare)
Subarachnoid haemorrhage induces an inflammatory response followed by a delayed persisting increase in asymmetric dimethylarginine
- Artikel/kapitelEngelska2012
Förlag, utgivningsår, omfång ...
-
2012-08-31
-
Informa UK Limited,2012
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:umu-55732
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-55732URI
-
https://doi.org/10.3109/00365513.2012.699098DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Object: Subarachnoid haemorrhage (SAH) is associated with an inflammatory systemic response and cardiovascular complications. Asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthase, mediates vasoconstriction and might contribute to cerebral vasoconstriction and cardiovascular complications after SAH. ADMA is also involved in inflammation and induces endothelial dysfunction.The aim of this study was to evaluate whether and how CRP (marker for systemic inflammation) and ADMA increased in patients during the acute phase (first week) after SAH. The ADMA level was also assessed in the patients in a non-acute phase (three months), and in healthy controls.Methods: Prospective study of 20 patients with aneurysmal SAH. ADMA and CRP were followed daily during the first week after SAH and a follow up sample for ADMA was obtained three months later. A single blood sample for ADMA was collected from age and sex matched healthy controls (n=40, 2 for each case).Results: CRP increased significantly from day 2; 16 (Confidence interval (CI) 10-23) mg/L to day 4; 84 (CI 47-120) mg/L, (p<0.01). ADMA increased significantly from day 2; 0.22 (CI 0.17-0.27) µmol/L, to day 7; 0.37 (CI 0.21-0.54) µmol/L, p<0.01. ADMA remained elevated at a three-month follow-up 0.36 (CI 0.31-0.42) µmol/L.ADMA in the first sample from the patients (day 1-3); 0.25 (CI 0.19-0.30) µmol/L, was not different from ADMA in matched healthy controls; 0.25 (CI 0.20-0.31), p>0.05.Conclusion: After SAH, CRP and ADMA in serum increased significantly during the first week and ADMA remained elevated three months later.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Olivecrona, MagnusUmeå universitet,Klinisk neurovetenskap(Swepub:umu)masola78
(författare)
-
Koskinen, Lars-OweUmeå universitet,Klinisk neurovetenskap(Swepub:umu)lako0002
(författare)
-
Naredi, SilvanaUmeå universitet,Anestesiologi och intensivvård(Swepub:umu)nasi0001
(författare)
-
Hultin, MagnusUmeå universitet,Anestesiologi och intensivvård(Swepub:umu)mahu0016
(författare)
-
Umeå universitetAnestesiologi och intensivvård
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Scandinavian Journal of Clinical and Laboratory Investigation: Informa UK Limited72:6, s. 484-4890036-55131502-7686
Internetlänk
Hitta via bibliotek
Till lärosätets databas